Cold Atmospheric Plasma Jet Treatment Improves Human Keratinocyte Migration and Wound Closure Capacity without Causing Cellular Oxidative Stress.

Aurélie Marches, Emily Clement, Géraldine Albérola, Marie-Pierre Rols, Sarah Cousty, Michel Simon, Nofel Merbahi

Journal: International journal of molecular sciences 2022;23(18):10650

PMID: 36142561

Abstract

Cold Atmospheric Plasma (CAP) is an emerging technology with great potential for biomedical applications such as sterilizing equipment and antitumor strategies. CAP has also been shown to improve skin wound healing in vivo, but the biological mechanisms involved are not well known. Our study assessed a possible effect of a direct helium jet CAP treatment on keratinocytes, in both the immortalized N/TERT-1 human cell line and primary keratinocytes obtained from human skin samples. The cells were covered with 200 µL of phosphate buffered saline and exposed to the helium plasma jet for 10−120 s. In our experimental conditions, micromolar concentrations of hydrogen peroxide, nitrite and nitrate were produced. We showed that long-time CAP treatments (≥60 s) were cytotoxic, reduced keratinocyte migration, upregulated the expression of heat shock protein 27 (HSP27) and induced oxidative cell stress. In contrast, short-term CAP treatments (<60 s) were not cytotoxic, did not affect keratinocyte proliferation and differentiation, and did not induce any changes in mitochondria, but they did accelerate wound closure in vitro by improving keratinocyte migration. In conclusion, these results suggest that helium-based CAP treatments improve wound healing by stimulating keratinocyte migration. The study confirms that CAP could be a novel therapeutic method to treat recalcitrant wounds.

Address: Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), Toulouse University, CNRS, Inserm, Université Paul Sabatier, Place du Dr Baylac, 31059 Toulouse, France.; Laboratoire des Plasmas et Conversion d'Énergie (LAPLACE), 118 Route de Narbonne, 31062 Toulouse, France.; Institut de Pharmacologie et de Biologie Structurale (IPBS), 205 Route de Narbonne, 31077 Toulouse, France.; UFR Odontologie, CHU Toulouse, 3 Chemin des Maraîchers, 31400 Toulouse, France.; Département de Chirurgie et Médecine Orales, Centre Hospitalo-Universitaire de Toulouse, 3 Chemin des Maraîchers, CEDEX 9, 31059 Toulouse, France.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.